Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

Nearly everyone with MS has signs of lesions in the brain, as shown by magnetic resonance imaging (MRI) scans, according to Anthony Reder, MD, a multiple sclerosis specialist and professor of ...

Researchers have discovered a novel biomarker for severe multiple sclerosis (MS). This research will contribute to our ...

Dr. Susan Payrovi and Dr. Mirla Avila have an in-depth discussion around treating MS, and considerations when selecting an MS ...

IMUX stock's drop appears to be an overreaction, given positive disability progression data and clean safety profile. Click ...

Basel, 30 May 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, 96-week data for fenebrutinib demonstrating that patients with relapsing multiple sclerosis (RMS) maintained no ...

(2000) T2 lesion volume and number of GAD-enhancing ... Relapsing–remitting multiple sclerosis. BPF: Brain parenchymal fraction; CIS: Clinically isolated syndrome; CTh: Cortical thickness ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

By the time her cancer was caught, six months after her symptoms began and two days after her 46th birthday, Louise Greenbank ...

A WOMAN has told how she was diagnosed with Multiple Sclerosis after noticing a strange symptom while driving. Affecting over ...

A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...